These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24795692)

  • 1. Dopamine and the biology of creativity: lessons from Parkinson's disease.
    Lhommée E; Batir A; Quesada JL; Ardouin C; Fraix V; Seigneuret E; Chabardès S; Benabid AL; Pollak P; Krack P
    Front Neurol; 2014; 5():55. PubMed ID: 24795692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
    Lhommée E; Klinger H; Thobois S; Schmitt E; Ardouin C; Bichon A; Kistner A; Fraix V; Xie J; Aya Kombo M; Chabardès S; Seigneuret E; Benabid AL; Mertens P; Polo G; Carnicella S; Quesada JL; Bosson JL; Broussolle E; Pollak P; Krack P
    Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do patient's get angrier following STN, GPi, and thalamic deep brain stimulation.
    Burdick AP; Foote KD; Wu S; Bowers D; Zeilman P; Jacobson CE; Ward HE; Okun MS
    Neuroimage; 2011 Jan; 54 Suppl 1():S227-32. PubMed ID: 20932923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
    Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
    Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal dopamine transporter availability and individual clinical course within the 1-year follow-up of deep brain stimulation of the subthalamic nucleus in patients with Parkinson's disease.
    Löser J; Luthardt J; Rullmann M; Weise D; Sabri O; Meixensberger J; Hesse S; Winkler D
    J Neurosurg; 2021 Nov; 135(5):1429-1435. PubMed ID: 33607613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile of Neuropsychiatric Symptoms in Parkinson's Disease: Surgical Candidates Compared to Controls.
    Lamberti VM; Pereira B; Lhommée E; Bichon A; Schmitt E; Pelissier P; Kistner A; Fraix V; Castrioto A; Esselink RA; Durif F; Krack P
    J Parkinsons Dis; 2016; 6(1):133-42. PubMed ID: 26889631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of unilateral subthalamic deep brain stimulation in highly asymmetrical Parkinson's disease: 7-year follow-up.
    Ehm G; Kim HJ; Kim JY; Lee JY; Kim HJ; Yun JY; Kim YE; Yang HJ; Lim YH; Jeon B; Paek SH
    J Neurosurg; 2019 Nov; 131(5):1508-1513. PubMed ID: 30497175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson's disease.
    Zhang F; Wang F; Li W; Wang N; Han C; Fan S; Li P; Xu L; Zhang J; Meng F
    BMC Neurol; 2021 Mar; 21(1):122. PubMed ID: 33731033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transporter imaging predicts motor responsiveness to levodopa challenge in patients with Parkinson's disease: A pilot study of DATSCAN for subthalamic deep brain stimulation.
    Nakajima A; Shimo Y; Sekimoto S; Kamagata K; Jo T; Oyama G; Umemura A; Hattori N
    J Neurol Sci; 2018 Feb; 385():134-139. PubMed ID: 29406893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective Study.
    Santin MDN; Voulleminot P; Vrillon A; Hainque E; Béreau M; Lagha-Boukbiza O; Wirth T; Montaut S; Bardinet E; Kyheng M; Rolland AS; Voirin J; Drapier S; Durif F; Eusebio A; Giordana C; Auzou N; Houeto JL; Hubsch C; Jarraya B; Laurencin C; Maltete D; Meyer M; Rascol O; Rouaud T; Tir M; Moreau C; Corvol JC; Proust F; Grabli D; Devos D; Tranchant C; Anheim M;
    Mov Disord; 2021 Mar; 36(3):750-757. PubMed ID: 33022101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of dopaminergic therapy on intraoperative microelectrode recordings for subthalamic deep brain stimulation under GA: can we operate on patients 'on medications'?
    Asha MJ; Kausar J; Krovvidi H; Shirley C; White A; Chelvarajah R; Hodson JA; Pall H; Mitchell RD
    Acta Neurochir (Wien); 2016 Feb; 158(2):387-93. PubMed ID: 26602236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic beta oscillations are attenuated after withdrawal of chronic high frequency neurostimulation in Parkinson's disease.
    Trager MH; Koop MM; Velisar A; Blumenfeld Z; Nikolau JS; Quinn EJ; Martin T; Bronte-Stewart H
    Neurobiol Dis; 2016 Dec; 96():22-30. PubMed ID: 27553876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of restless legs syndrome after subthalamic stimulation in Parkinson's disease: a dopaminergic overstimulation?
    Marques A; Fantini ML; Morand D; Pereira B; Derost P; Ulla M; Debilly B; Lemaire JJ; Durif F
    Sleep Med; 2015 May; 16(5):583-8. PubMed ID: 25881920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease.
    Martinez-Fernandez R; Pelissier P; Quesada JL; Klinger H; Lhommée E; Schmitt E; Fraix V; Chabardes S; Mertens P; Castrioto A; Kistner A; Broussolle E; Pollak P; Thobois S; Krack P
    J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):311-8. PubMed ID: 25934016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation on gait kinematics in Parkinson's disease: a randomized, blinded study.
    Lizarraga KJ; Jagid JR; Luca CC
    J Neurol; 2016 Aug; 263(8):1652-6. PubMed ID: 27278062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical outcomes of bilateral GPi deep brain stimulation in advanced Parkinson's disease: 5 years and beyond.
    Tsuboi T; Lemos Melo Lobo Jofili Lopes J; Moore K; Patel B; Legacy J; Ratajska AM; Bowers D; Eisinger RS; Almeida L; Foote KD; Okun MS; Ramirez-Zamora A
    J Neurosurg; 2021 Aug; 135(2):601-610. PubMed ID: 33035998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subthalamic nucleus deep brain stimulation improves dyskinesias in Parkinson's disease beyond levodopa reduction.
    Mossner JM; Patil PG; Chou KL
    J Neural Transm (Vienna); 2019 Nov; 126(11):1479-1483. PubMed ID: 31494731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.